Sutro Biopharma, Inc 10-Q for FY2020 Q2
Sutro Biopharma, Inc. (STRO)
10-Q
2020-08-06
For: 2020-06-30
View Original
Added on
April 11, 2026
About this 10-Q
Sutro Biopharma, Inc filed this 10-Q on August 6, 2020, covering the quarter ended June 30, 2020 (FY2020 Q2).
Headline figures
Quarter ended June 30, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $9.47M
- down 10.0% from $10.53M a year earlier
- Net income
- $29.87M
- compared with a net loss of $13.79M a year earlier
- Diluted EPS
- $0.94
- compared with -$0.60 a year earlier